2 results
Approved WMORecruiting
To compare the tidal volume distribution and other ventilator parameters between PAV+ and NAVA.
Approved WMORecruiting
PRIMARY: Dose finding part (Phase 1):To assess the safety and tolerability of durvalumab when given in combination with lenalidomide and rituximab; ibrutinib; or bendamustine and rituximab to determine the recommended Phase 2 doses (RP2Ds) of each…